Our Oligonucleotides facility offers end-to-end services, from early discovery to cGMP manufacturing. Specialty areas include chemically synthesized high-quality modified and non-modified custom oligonucleotide (DNA/RNA); siRNA (single & double-stranded); miRNA (modified and non-modified); antisense oligonucleotides; phosphodiesters and morpholinos; all types of oligo conjugates, and all types of base and custom modifications.

Syngene’s state-of-the-art small molecule cGMP manufacturing facility is USFDA and PMDA-approved. The facility manufactures clinical (early and late-phase) and commercial drug substances (NCEs), advanced intermediates, regulatory starting materials, and selected generic APIs for clients. The facility’s manufacturing output ranges from grams to hundreds of kilograms per batch, with total volumes ranging from 60L to 8000L.

Our high potent API facility is designed to handle cytotoxic and cytostatic high-potency compounds with a commitment to safety. It has an occupational exposure limit (OEL) of up to 0.01 µg/m over 8 hours and is categorized within Band 4/5. The cGMP facility is positioned to meet the stringent requirements of the regulated market. Additionally, it boasts an integrated cGMP facility dedicated to manufacturing non-potent compounds.

Our Quality Control Biologics lab uses the latest technology and equipment for testing biologics products, with a strong focus on digitalization and automation. Our stringent quality control procedures and standards ensure the accuracy and reliability of results. Further, we are one of the pioneers of real-wear-assisted reality glasses for collaborative technology transfer and hosting remote inspections in alignment with FDA guidelines.

Our GMP-certified, API manufacturing facility in Mangalore is a state-of-the-art, multi-product, multi-client, contract facility. Spread across 46 acres, it is designed to support all large-scale API and advanced intermediate manufacturing requirements of our clients.

Explore Syngene’s Large Molecule Bioanalytical Laboratory, which is India’s premier GLP- certified and GCLP-compliant lab. It specializes in immunogenicity and pharmacokinetic (PK) analysis of biologics and biosimilars.

Explore our new 52,000 sq. ft., state-of-the-art R&D center in Genome valley, Hyderabad. Focused on Discovery Chemistry services, we are excited to be expanding our facilities to assist more clients accelerate their research programs.

Watch this video on our early-stage Chemistry Process Research lab for drug discovery that supports pre-clinical studies, medicinal chemistry, and integrated project requirements (from mg to kg scale).

In this video, Syngene scientist Saurabh Sahu takes you through the capabilities and features of our integrated Sterile Fill-Finish facility for clinical supplies of Biologics and Small Molecules, as well as, products that are sensitive to light, heat and oxygen.

Want to know, how Syngene conducts RT-PCR testing at its COVID-19 Testing laboratory? Approved by Indian Council of Medical Research (ICMR), this lab has tested more than 100000+ samples so far.